KRAS Footprints in the Skin: Leveraging Targeted Therapy for Unresectable Intra‐Cerebral AVM
Pediatric Dermatology · 2025
DOI: 10.1111/pde.70126 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Dermatology, 2025. Verfasst von Donglin Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Wisconsin School of Medicine, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Pyridones, Proto-Oncogene Proteins p21(ras), Intracranial Arteriovenous Malformations, Pyrimidinones. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A 15‐year‐old female with a longstanding, unresectable intracerebral arteriovenous malformation (AVM) involving the bilateral thalami and basal ganglia presented with progressive neurologic decline. Given the inaccessibility of the intracranial lesion, a lipomatous scalp nodule overlying the AVM was biopsied for molecular testing and revealed a somatic mosaic KRAS p.G12D variant, the most common variant detected in sporadic brain AVMs. Targeted therapy with the MEK inhibitor trametinib was initiated, but the treatment course was complicated by cutaneous toxicity and ongoing neurologic deterioration. This case illustrates that extracranial tissue in the skin can serve as a surrogate for molecular diagnosis in unresectable brain AVMs, underscoring the diagnostic and therapeutic importance of dermatologic assessment in complex vascular anomalies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Wisconsin School of Medicine, Madison, Wisconsin, USA.
- Department of Neurology, University of Wisconsin School of Medicine, Madison, Wisconsin, USA.
- Department of Neurological Surgery, University of Wisconsin School of Medicine, Madison, Wisconsin, USA.
- Department of Radiology, University of Wisconsin School of Medicine, Madison, Wisconsin, USA.
- Division of Hematology, Oncology, Transplant and Cellular Therapy, University of Wisconsin School of Medicine, Madison, Wisconsin, USA.
ORCID-Profile: Donglin Zhang
Zitieren
APA
Zhang, D., Kwon, J. M., Aagaard-Kienitz, B., Rebsamen, S. L., Mc Dermott, S. E., & Arkin, L. M. (2025). KRAS Footprints in the Skin: Leveraging Targeted Therapy for Unresectable Intra‐Cerebral AVM. Pediatric Dermatology. https://doi.org/10.1111/pde.70126
Vancouver
Zhang D, Kwon JM, Aagaard-Kienitz B, Rebsamen SL, Mc Dermott SE, Arkin LM. KRAS Footprints in the Skin: Leveraging Targeted Therapy for Unresectable Intra‐Cerebral AVM. Pediatric Dermatology. 2025. doi:10.1111/pde.70126
BibTeX
@article{Zhang2025,
author = {Zhang, Donglin and Kwon, Jennifer M and Aagaard-Kienitz, Beverly and Rebsamen, Susan L and Mc Dermott, Sarah E and Arkin, Lisa M},
title = {KRAS Footprints in the Skin: Leveraging Targeted Therapy for Unresectable Intra‐Cerebral AVM},
journal = {Pediatric Dermatology},
year = {2025},
doi = {10.1111/pde.70126}
}
EUVIMED